Author/Creator: You, X - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator You, X

1. A215 EVALUATING THE COMPARABILITY OF CARE FOR PERSONS ADMITTED TO TORONTO AREA HOSPITALS WITH ACUTE SEVERE ULCERATIVE COLITIS. (7th March 2023)

Authors:: Vukovic, S; You, X; Roberts, S; Razak, F; Verma, A; Targownik, L
Journal:: Journal of the Canadian Association of Gastroenterology
Issue:: Volume 6(2023)Supplement 1
Page Start:: 52
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Atmospheric monitoring strategy for the Ali site, Tibet. (March 2015)

Authors:: Yao, Y; Zhou, Y; Liu, L; Wang, H; Yin, J; You, X; Fu, X
Journal:: Journal of physics
Issue:: Number 595 (2015)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Clinical characteristics and therapy exploration of active human cytomegalovirus infection in 105 lupus patients. (August 2014)

Authors:: Zhang, J; Dou, Y; Zhong, Z; Su, J; Xu, D; Tang, F; Zhang, X; Zhao, Y; Zeng, X; Zhang, F; You, X
Journal:: Lupus
Issue:: Volume 23:Number 9(2014)
Page Start:: 889
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Effect of intramuscular interferon beta-1a on gray matter atrophy in relapsing−remitting multiple sclerosis: A retrospective analysis. (April 2016)

Authors:: Fisher, E; Nakamura, K; Lee, J-C; You, X; Sperling, B; Rudick, RA
Journal:: Multiple sclerosis
Issue:: Volume 22:Number 5(2016)
Page Start:: 668
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Mycoplasma pneumoniae lipids license TLR-4 for activation of NLRP3 inflammasome and autophagy to evoke a proinflammatory response. (29th September 2020)

Authors:: Luo, H; He, J; Qin, L; Chen, Y; Chen, L; Li, R; Zeng, Y; Zhu, C; You, X; Wu, Y
Journal:: Clinical and experimental immunology
Issue:: Volume 203:Number 1(2021)
Page Start:: 66
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. S67 Effects of tezacaftor/ivacaftor (TEZ/IVA) treatment in patients heterozygous for F508del-CFTR and a residual function mutation: patient-reported outcomes in a phase 3 randomized, controlled trial (EXPAND). (December 2018)

Authors:: Chuang, C-C; Rizio, AA; Loop, B; Lekstrom-Himes, J; You, X; Kosinski, M; Rendas-Baum, R; Davies, JC; Rowe, SM; Yang, Y
Journal:: Thorax
Issue:: Volume 73(2018)Supplement 4
Page Start:: A41
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

7. S68 Effects of tezacaftor/ivacaftor (TEZ/IVA) treatment in patients with cystic fibrosis homozygous for F508del-CFTR: patient-reported outcomes in a phase 3 randomized, controlled trial (EVOLVE). (December 2018)

Authors:: Yang, Y; Rizio, AA; Chuang, C-C; Loop, B; You, X; Kosinski, M; Rendas-Baum, R; Lekstrom-Himes, J; Taylor-Cousar, J; Sole, A; Elborn, JS
Journal:: Thorax
Issue:: Volume 73(2018)Supplement 4
Page Start:: A42
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

8. Ten-year follow-up of the 'minimal MRI lesion' subgroup from the original CHAMPS Multiple Sclerosis Prevention Trial. (April 2015)

Authors:: Simon, JH; Kinkel, RP; Kollman, C; O'Connor, P; Fisher, E; You, X; Hyde, R
Journal:: Multiple sclerosis
Issue:: Volume 21:Number 4(2015)
Page Start:: 415
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗